New Framework Needed to Assess Safety of Microbiome-Targeting Products

Human microbiomes play crucial roles in health and disease, yet assessing the safety of products designed to intentionally modify these complex ecosystems presents significant challenges. This comprehensive review, inspired by discussions from an academic-industry workshop, addresses the growing need for robust safety assessment frameworks as microbiome-targeting products become increasingly prevalent.

The authors examine three key microbiome sites: oral, skin, and gut ecosystems. They note that while everyday activities like eating, tooth brushing, and applying cosmetics naturally modulate our microbiomes, advances in sequencing technologies are now driving development of products specifically designed to target microbial communities. These range from probiotics and prebiotics to more complex interventions, each presenting unique regulatory and safety considerations.

Key challenges identified include substantial confounding factors such as ecological variability, host influences, and external conditions like geography, diet, and medication use. The review highlights biases from experimental measurements and bioinformatics analyses that complicate interpretation of microbiome changes. Perhaps most critically, researchers struggle to establish clear links between microbiome perturbations and long-term health outcomes, particularly in vulnerable populations like infants.

The authors propose several promising solutions. Emerging technologies including omics approaches to characterize microbiome functions rather than just taxonomic composition, artificial intelligence to interpret complex clinical data, and sophisticated in vitro models to measure host-microbiome interactions could all enhance risk assessments. They emphasize the importance of detailed documentation, transparency in computational models, and harmonization of methods across the field.

The review concludes that while standardized approaches could help bridge regulatory gaps and streamline safety assessments, frameworks must remain flexible enough to accommodate innovation and technological advances. The authors stress that continued scientific collaboration, public engagement, and long-term microbiome monitoring are essential for developing robust, fit-for-purpose approaches to assess the safety of microbiome-targeting interventions.